FREDUN PHARMACEUTICALS LIMITED BOARD MEETING HELD ON OCTOBER 03, 2026

• Board allotted 1,82,400 equity shares of face value Rs. 10/- each to non-promoter allottees upon conversion of 60,800 warrants. • This follows shareholders' approval in EGM on October 22, 2025, for allotting convertible warrants on preferential basis on December 29, 2025. • Warrant holders paid balance consideration and exercised rights for conversion. • The shares allotted rank pari passu with existing equity shares. • The meeting commenced at 04:00 p.m. and concluded at 05:15 p.m. Impact: Neutral (Routine corporate action for share allotment)

Fredun Pharmaceuticals Ltd

Open attachment

← Back to feed